Delving into the Latest Updates on Beijing Shihong Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Respiratory Diseases

Small molecule drug

Diagnostic radiopharmaceuticals

Synthetic peptide

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	2

Top 5 Drug Type	Count

Small molecule drug	2
Diagnostic radiopharmaceuticals	2
Synthetic peptide	1

Primary objective: To evaluate the effectiveness of stannous galactosyl human serum albumin diethylenetriamine pentaacetate for injection in clinical liver function assessment; Secondary objective: To evaluate the safety of stannous galactosyl human serum albumin diethylenetriamine pentaacetate for injection in liver function assessment.

Start Date09 Jun 2021

Sponsor / Collaborator

Peking Union Medical College Hospital

[+1]

CTR20191555

/ CompletedPhase 1

99mTc-GSA注射液在中国健康志愿者体内的药代动力学和安全性的I期临床研究

[Translation] Phase I clinical study on the pharmacokinetics and safety of 99mTc-GSA injection in Chinese healthy volunteers

主要目的：评估锝[99mTc]半乳糖酰人血清白蛋白二亚乙基三胺五乙酸盐（99mTc-GSA）注射液在健康志愿者体内的药代动力学特征；次要目的：评估锝[99mTc]半乳糖酰人血清白蛋白二亚乙基三胺五乙酸盐（99mTc-GSA）注射液单次给药在健康受试者中的安全性和耐受性。

[Translation]

Primary objective: To evaluate the pharmacokinetic characteristics of technetium [99mTc] galactosyl human serum albumin diethylenetriamine pentaacetate (99mTc-GSA) injection in healthy volunteers; Secondary objective: To evaluate the safety and tolerability of single-dose technetium [99mTc] galactosyl human serum albumin diethylenetriamine pentaacetate (99mTc-GSA) injection in healthy subjects.

Start Date29 Nov 2019

Sponsor / Collaborator

Peking Union Medical College Hospital

[+1]

CTR20230384

/ Not yet recruitingPhase 1

锝[99mTc]异腈葡萄糖注射液在健康受试者体内的药代动力学和安全性的I期临床研究

[Translation] Phase I clinical study on the pharmacokinetics and safety of technetium [99mTc] isonitrile glucose injection in healthy volunteers

主要目的：检测试验药物在健康受试者体内的药代动力学，以及在人体内的生物分布及估算内照射辐射吸收剂量，为II期临床研究方案设计提供依据。次要目的观察试验药物对健康受试者的安全性。

[Translation]

Main purpose: To detect the pharmacokinetics of the test drug in healthy subjects, as well as its biodistribution in the human body and estimate the internal radiation absorption dose, so as to provide a basis for the design of the Phase II clinical study. Secondary purpose To observe the safety of the test drug in healthy subjects.

Start Date-

Sponsor / Collaborator

Beijing Shihong Pharmaceutical Co., Ltd.

100 Clinical Results associated with Beijing Shihong Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Shihong Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Beijing Shihong Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Shihong Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

2

1

NDA/BLA

Other

5

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

99mTcN-Isonitrile glucose	Neoplasms More	Phase 1
99mTc N-Isonitrile Glucosamine	Non-Small Cell Lung Cancer More	Phase 1
99m Tc- 6	Neoplasms More	Discontinued
Technetium(99mTc) Galactosyl Human Serum Albumin Diethylenetriamine Pentaacetic Acid	Liver Diseases More	Pending
Methyldithiocarbazate and stannous chloride	Contrast agents More	Pending